Hopp til hovedinnhold

Sarkoidose

Sist revidert:
Sist revidert av:
Definisjon:
Idiopatisk, granulomatøs systemsykdom som oftest affiserer lunger og intratorakale lymfeknuter, men også ekstratorakale manifestasjoner er hyppige
Forekomst:
Usikre tall, tilstanden er ofte asymptomatisk. Insidens er 5-18 per 100000 per år. Debuterer hyppigst i aldersgruppen 30-55 år 
Symptomer:
30-50% er symptomfrie og oppdages ved et tilfeldig rtg. thorax. Symptomatisk sykdom debuterer enten akutt eller smygende. Hoste, tungpusthet, diffuse brystsmerter, ev. slitenhet og sykdomsfølelse
Funn:
Alle organer kan affiseres, men hyppigst lunger, hud, lymfeknuter, lever. Som regel få eller ingen organiske funn
Diagnostikk:
Finnes ingen definitiv diagnostisk test. Røntgen, ev. CT, blodprøver, histologi
Behandling:
Selvhelbredende hos en god del pasienter. Ved progressiv sykdom behandles med kortikosteroider, ev. immunsupprimerende eller biologiske medisiner, ev. transplantasjon
  1. Soto-Gomez N, Peters JI. Diagnosis and management of sarcoidosis. Am Fam Physician. 2016 May 15;93(10):840-850.
  2. Drent M, Crouser ED, Grunewald J. Challenges of Sarcoidosis and Its Management. N Engl J Med. 2021;385(11):1018-1032. PubMed  
  3. Shinn J, Paauw DS. The Management of Sarcoidosis: A Primary Care Approach. Med Clin North Am. 2015;99:1123-48. doi: 10.1016/j.mcna.2015.05.008 DOI  
  4. Grunewald J, Grutters JC, Arkema EV, Saketkoo LA, Moller DR, Müller-Quernheim J. Sarcoidosis published correction appears in Nat Rev Dis Primers. 2019 Jul 16;5(1):49. Nat Rev Dis Primers. 2019;5(1):45. PMID: 31273209 PubMed  
  5. Stavem K. Sarkoidose. Norsk legemiddelhåndbok, sist oppdatert 20.07.2020. www.legemiddelhandboka.no  
  6. Boeck C. Multiple benign sarcoid of the skin. J Cutan Genitourin Dis 1899; 17: 543-50. PubMed  
  7. Norsk sarkoidose forening i samarbeid med Norsk forening for lungemedisin: Faglige retningslinjer for sarkoidose, 2022. Oversatt fra Svensk Lungmedicinsk Förenings Vårdprogram för Sarkoidos 2014 (oppdatert 2018 og 2021). Oversetter: Trond Bjørge. Språklig gjennomgang: Karin Saastad-Rühl. sarkoidose.no  
  8. King TE. Clinical manifestations and diagnosis of pulmonary sarcoidosis. UpToDate, last updated Mar 24, 2022. www.uptodate.com  
  9. Arkema EV, Cozier YC. Epidemiology of sarcoidosis: current findings and future directions. Ther Adv Chronic Dis 2018; 9(11): 227-240. pmid:30364496 PubMed  
  10. Valeyre D, Prasse A, Nunes H, et al. Sarcoidosis. Lancet. 2014 Mar 29;383(9923):1155-67. pmid: 24090799 PubMed  
  11. King TE. Treatment of pulmonary sarcoidosis: Initial therapy with glucocorticoids. UpToDate, last updated Jan 25, 2017. UpToDate  
  12. Voortman M, Drent M, Baughman RP. Management of neurosarcoidosis: a clinical challenge. Curr Opin Neurol. 2019;32(3):475-483. PMID: 30865007 PubMed  
  13. Birnie DH, Sauer WH, Bogun F, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. 2014;11(7):1305–1323.
  14. Kouranos V, Sharma R. Cardiac sarcoidosis: state-of-the-art review. Heart 2021. doi:10.1136/heartjnl-2019-316442 DOI  
  15. Sohn D-W, Park J-B. Cardiac sarcoidosis. Heart 2023. pmid:36631144 PubMed  
  16. Brown F, Modi P, Tanner LS. Lofgren Syndrome. In: StatPearls. Treasure Island (FL): StatPearls Publishing; August 1, 2022.
  17. Sand M, Sand D, Thrandorf C. Cutaneous lesions of the nose. Head Face Med 2010. pmid:20525327 PubMed  
  18. Dempsey OJ, Paterson EW, Kerr KM, Denison AR. Sarcoidosis. Clinical review. BMJ 2009; 339: b3206. BMJ (DOI)  
  19. Tan JL, Fong HK, Birati EY, Han Y. Cardiac Sarcoidosis. Am J Cardiol. 2019;123(3):513-522. PMID: 30503798 PubMed  
  20. Kraaijvanger R, Janssen Bonás M, Vorselaars ADM, Veltkamp M. Biomarkers in the diagnosis and prognosis of sarcoidosis: current use and future prospects. Front Immunol 2020;11:1443-1443. PubMed  
  21. Ungprasert P, Carmona EM, Crowson CS, Matteson EL. Diagnostic Utility of Angiotensin-Converting Enzyme in Sarcoidosis: A Population-Based Study. Lung 2016; 194:91. PubMed  
  22. Thillai M, Atkins CP, Crawshaw A, et al. BTS Clinical Statement on pulmonary sarcoidosis. Thorax 2021; 76:4. PubMed  
  23. Sobic-Saranovic D, Artiko V, Obradovic V. FDG PET imaging in sarcoidosis. Semin Nucl Med. 2013;43(6):404–411.
  24. von Bartheld MB, Dekkers OM, Szlubowski A, et al. Endosonography vs conventional bronchoscopy for the diagnosis of sarcoidosis: the GRANULOMA randomized clinical trial. JAMA. 2013;309(23):2457–2464.
  25. Eurelings LEM, Miedema JR, Dalm VASH, et al. Sensitivity and specificity of serum soluble interleukin-2 receptor for diagnosing sarcoidosis in a population of patients suspected of sarcoidosis. PLoS One. 2019;14(10):e0223897. Published 2019 Oct 17. doi:10.1371/journal.pone.0223897 DOI  
  26. Moor CC, Kahlmann V, Culver DA, Wijsenbeek MS. Comprehensive care for patients with sarcoidosis. J Clin Med 2020;9:390-390. PubMed  
  27. Saketkoo LA, Russell AM, Jensen K, et al. Health-related quality of life (HRQoL) in sarcoidosis: diagnosis, management, and health outcomes. Diagnostics (Basel) 2021;11:1089-1089. PubMed  
  28. Drent M, Costabel U, Crouser ED, Grunewald J, Bonella F. Misconceptions regarding symptoms of sarcoidosis. Lancet Respir Med 2021;9:816-818. PubMed  
  29. Kamangar N. Sarcoidosis. Medscape, last updated Jun 20, 2019. emedicine.medscape.com  
  30. Pawate S. Sarcoidosis and the Nervous System. Continuum (Minneap Minn). 2020;26(3):695-715. PMID: 32487903 PubMed  
  31. Rahaghi FF, Baughman RP, Saketkoo LA, et al. Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis. Eur Respir Rev 2020;29:190146-190146. PubMed  
  32. Spagnolo P, Rossi G, Trisolini R, Sverzellati N, Baughman RP, Wells AU. Pulmonary sarcoidosis. Lancet Respir Med. 2018;6(5):389-402. PMID: 29625772 PubMed  
  33. Muthiah MP, Gamal AE. Sarcoidosis. BMJ Best Practice, last updated 28 Mar 2018. bestpractice.bmj.com  
  34. Pande A, Culver DA. Knowing when to use steroids, immunosuppressants or biologics for the treatment of sarcoidosis. Expert Rev Respir Med 2020;14:285-298. PubMed  
  35. Baughman RP, Lower EE. Treatment of Sarcoidosis. Clin Rev Allergy Immunol. 2015;49(1):79-92. PubMed  
  36. Al-Kofahi K, Korsten P, Ascoli C, et al. Management of extrapulmonary sarcoidosis: challenges and solutions. Ther Clin Risk Manag. 2016;12:1623-1634. Published 2016 Nov 7. PMID: 27853374 PubMed  
  37. Yang SJ, Salek S, Rosenbaum JT. Ocular sarcoidosis: new diagnostic modalities and treatment. Curr Opin Pulm Med. 2017;23(5):458-467. PubMed  
  38. Weill D, Benden C, Corris PA, et al. A consensus document for the selection of lung transplant candidates: 2014—an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2015;34(1):1–15.
  39. Ungprasert P, Crowson CS, Matteson EL.   Risk of cardiovascular disease among patients with sarcoidosis: a population-based retrospective cohort study, 1976-2013. Eur Respir J. 2017. PMID: 28182567 PubMed  
  40. Rossides M, Kullberg S, Askling J et al. Sarcoidosis mortality in Sweden: a population-based cohort study. Eur Respir J 2018. pmid:29467203 PubMed  
  • Terje Johannessen, professor i allmennmedisin, Trondheim
  • Peter Jost, spesialist i allmennmedisin, redaktør NEL, Trondheim

Tidligere fagmedarbeidere

  • Hasse Melbye, spesialist i allmennmedisin, førsteamanuensis ved institutt for samfunnsmedisin, Universitetet i Tromsø
  • Helge Bjørnstad Pettersen, overlege/førsteamanuensis, Lungeavdelingen, Regionsykehuset i Trondheim og Norges Teknisk Naturvitenskapelige Universitet, Trondheim